Evidence map›Paper›PMID 17670967›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2007

Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Raad Nashmi, Cheng Xiao, Purnima Deshpande, Sheri McKinney, Sharon R Grady, Paul Whiteaker, Qi Huang, Tristan McClure-Begley, Jon M Lindstrom, Cesar Labarca and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 267 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Synthetic cooling agents enhance nicotine reinforcement and mesolimbic dopamine signaling.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  4. Review
  5. Continuous Nicotine Monitors for Personal Nicotine Pharmacokinetics: A Receptor-Aware Research Agenda.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The many enigmas of nicotine.Advances in pharmacology (San Diego, Calif.) · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Chemical Flavorants in Vaping Products Alter Neurobiology in a Sex-Dependent Manner to Promote Vaping-Related Behaviors.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Raad NashmiDivision of Biology, California Institute of Technology, Pasadena, California 91125, USA.
Cheng Xiao
Purnima Deshpande
Sheri McKinney
Sharon R Grady
Paul Whiteaker
Qi Huang
Tristan McClure-Begley
Jon M Lindstrom
Cesar Labarca
Allan C Collins
Michael J Marks
Henry A Lester
California Institute of Technology · USUniversity of Colorado Boulder · USUniversity of Pennsylvania · US

Funding

Project 3 University of Colorado, BoulderU19DA019375 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI MARKS, MICHAEL J · 2005 to 2014
$8.3M
GENETICS OF NICOTINE TOLERANCE: ROLE OF RECEPTORSR01DA003194 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 1985 to 2013
$5.5M
STUDIES USING PURIFIED ACETYLCHOLINE RECEPTORSR01NS011323 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI LINDSTROM, JON MARTIN · 1985 to 2012
$5.0M
Studies with Nicotinic Null Mutant MiceP30DA015663 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI MARKS, MICHAEL J · 2003 to 2013
$4.5M
Alpha4 Nicotinic Receptor in Addiction: Mouse ModelsR01DA017279 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 2004 to 2014
$3.5M
NICOTINIC SYNAPSES, BIOPHYSICAL STUDIESR01NS011756 · NINDS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 1985 to 2009
$3.4M
MONOAMINE TRANSPORTERS--STRUCTURE AND FUNCTIONR01DA009121 · NIDA · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI LESTER, HENRY A. · 1994 to 2007
$2.4M
Immunochemical Protocols for Nicotinic ReceptorsR21DA019655 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WHITEAKER, PAUL · 2005 to 2006
$404k
NIDA NIH HHS DA-09121NIDA NIH HHS DA-15663NIDA NIH HHS DA-17279NIDA NIH HHS DA-19375NIDA NIH HHS DA-19655NIDA NIH HHS DA-3194NIDA NIH HHS P30 DA015663NIDA NIH HHS R01 DA003194NIDA NIH HHS R01 DA009121NIDA NIH HHS R01 DA017279NIDA NIH HHS R21 DA019655NIDA NIH HHS U19 DA019375NINDS NIH HHS NS-11323NINDS NIH HHS NS-11756NINDS NIH HHS R01 NS011323NINDS NIH HHS R01 NS011756
6 · The paper itself

Abstract

Understanding effects of chronic nicotine requires identifying the neurons and synapses whose responses to nicotine itself, and to endogenous acetylcholine, are altered by continued exposure to the drug. To address this problem, we developed mice whose alpha4 nicotinic receptor subunits are replaced by normally functioning fluorescently tagged subunits, providing quantitative studies of receptor regulation at micrometer resolution. Chronic nicotine increased alpha4 fluorescence in several regions; among these, midbrain and hippocampus were assessed functionally. Although the midbrain dopaminergic system dominates reward pathways, chronic nicotine does not change alpha4* receptor levels in dopaminergic neurons of ventral tegmental area (VTA) or substantia nigra pars compacta. Instead, upregulated, functional alpha4* receptors localize to the GABAergic neurons of the VTA and substantia nigra pars reticulata. In consequence, GABAergic neurons from chronically nicotine-treated mice have a higher basal firing rate and respond more strongly to nicotine; because of the resulting increased inhibition, dopaminergic neurons have lower basal firing and decreased response to nicotine. In hippocampus, chronic exposure to nicotine also increases alpha4* fluorescence on glutamatergic axons of the medial perforant path. In hippocampal slices from chronically treated animals, acute exposure to nicotine during tetanic stimuli enhances induction of long-term potentiation in the medial perforant path, showing that the upregulated alpha4* receptors in this pathway are also functional. The pattern of cell-specific upregulation of functional alpha4* receptors therefore provides a possible explanation for two effects of chronic nicotine: sensitization of synaptic transmission in forebrain and tolerance of dopaminergic neuron firing in midbrain.

Indexed as

AnimalsDose-Response Relationship, DrugDrug ToleranceLong-Term PotentiationMesencephalonMiceMice, Inbred C57BLMice, KnockoutNicotinePerforant PathwayReceptors, NicotinicUp-RegulationNicotinenicotinic receptor alpha4beta2Receptors, Nicotinic

Identifiers

PMID17670967
PMCPMC6673074
OpenAlexW2082275787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.